Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 293
Selected: 0
NCT IDTitle
NCT00775931Allogeneic Transplantation For Severe Osteopetrosis
NCT05735717MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
NCT00392782Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
NCT01043640Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
NCT00287859Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00276159Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
NCT00287885Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
NCT00005985Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
NCT04629209A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
NCT00003926Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
NCT00610740CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
NCT02765997StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies
NCT00176878Stem Cell Transplant for Bone Marrow Failure Syndromes
NCT03213964Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
NCT02661035Allo HSCT Using RIC for Hematological Diseases
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT04969783Telehealth-Filter Ventilation ( COMET2P1 )
NCT01505569Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
NCT06411795Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT05665543Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
NCT01400672Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
NCT00293293Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine
NCT01173016Administration of IV Laronidase Post Bone Marrow Transplant in Hurler
NCT00620295Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
NCT03651037Physical Activity Platform to Improve Bone Health in Cancer Survivors
NCT01639456CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
NCT00869323Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
NCT03850704Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
NCT00369291CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
NCT00352976TBI Dose De-escalation for Fanconi Anemia
NCT00346125PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
NCT07541573GTB-5550 in Advanced Solid Tumors
NCT00617188Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
NCT00352118Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
NCT05643014Observational Study of Exposure to Environmental Toxicants Among Firefighters
NCT03850691Radiation and Combination Immunotherapy for Melanoma
NCT04105270RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
NCT01105650Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
NCT00295880Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
NCT00643240Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia
NCT01163201T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
NCT03579875Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
NCT02948062Early Diagnosis Of Childhood Cerebral ALD
NCT01009437Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
NCT05502302App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT03297463Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
NCT00365287Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer